These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2612617)

  • 1. Qualitative platelet defects in chronic myeloproliferative disorders: evidence for reduced ATP secretion.
    Löfvenberg E; Nilsson TK
    Eur J Haematol; 1989 Nov; 43(5):435-40. PubMed ID: 2612617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormalities of platelet adenine nucleotides in patients with myeloproliferative disorders.
    Nishimura J; Okamoto S; Ibayashi H
    Thromb Haemost; 1979 Jun; 41(4):787-95. PubMed ID: 483250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ATP and ADP of platelets in chronic myeloproliferative disorders and multiple myeloma].
    Terada H; Ohshima M
    Rinsho Ketsueki; 1989 Jan; 30(1):22-8. PubMed ID: 2716195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of platelet aggregation in chronic myeloproliferative disorders.
    Avram S; Lupu A; Angelescu S; Olteanu N; Mut-Popescu D
    J Cell Mol Med; 2001; 5(1):79-87. PubMed ID: 12067453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis].
    Hochhaus A; Mindner K; Ostermann G; Höche D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):765-70. PubMed ID: 1713878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders.
    Yamamoto K; Sekiguchi E; Takatani O
    Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet function in patients with high platelet counts.
    Ginsburg AD
    Ann Intern Med; 1975 Apr; 82(4):506-11. PubMed ID: 1054537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a platelet membrane defect in the myeloproliferative syndromes.
    Castaldi PA; Berndt MC; Booth W; Gregory C; Bull H; Greaves M
    Thromb Res; 1982 Sep; 27(5):601-9. PubMed ID: 6960545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
    Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
    Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating activated platelets in myeloproliferative disorders.
    Wehmeier A; Tschöpe D; Esser J; Menzel C; Nieuwenhuis HK; Schneider W
    Thromb Res; 1991 Feb; 61(3):271-8. PubMed ID: 1709309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary thrombocythaemia in childhood.
    Linch DC; Hutton R; Cowan D; Moore AR; Richards JD; Wilkinson LS
    Scand J Haematol; 1982 Jan; 28(1):72-6. PubMed ID: 7071518
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet aggregation in platelet-rich plasma and whole blood in 120 patients with myeloproliferative disorders.
    Balduini CL; Bertolino G; Noris P; Piletta GC
    Am J Clin Pathol; 1991 Jan; 95(1):82-6. PubMed ID: 1987755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum of platelet aggregation abnormalities in myeloproliferative diseases.
    Cortelazzo S; Viero P; Bassan R; Barbui T
    Ric Clin Lab; 1981; 11(1):35-42. PubMed ID: 7221403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet function in preleukaemia.
    Lintula R; Rasi V; Ikkala E; Borgström GH; Vuopio P
    Scand J Haematol; 1981 Jan; 26(1):65-71. PubMed ID: 7466320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic myeloproliferative disorders: improved platelet aggregation following venesection.
    Boughton BJ
    Br J Haematol; 1978 Aug; 39(4):589-98. PubMed ID: 698130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet aggregation responses vary over a period of time in healthy controls.
    Refaai MA; Frenkel E; Sarode R
    Platelets; 2010; 21(6):460-3. PubMed ID: 20536288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function.
    Barbui T; Cortelazzo S; Viero P; Bassan R; Dini E; Semeraro N
    Eur J Cancer Clin Oncol; 1983 Nov; 19(11):1593-9. PubMed ID: 6580171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADP-induced platelet aggregation and thrombin generation are increased in Essential Thrombocythemia and Polycythemia Vera.
    Panova-Noeva M; Marchetti M; Russo L; Tartari CJ; Leuzzi A; Finazzi G; Rambaldi A; ten Cate H; Falanga A
    Thromb Res; 2013 Jul; 132(1):88-93. PubMed ID: 23735588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disorders.
    Wehmeier A; Fricke S; Scharf RE; Schneider W
    Eur J Haematol; 1990 Oct; 45(4):191-7. PubMed ID: 2146144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of platelet activation in myeloproliferative disorders with complementary techniques.
    Bermejo E; Alberto MF; Meschengieser SS; Lazzari MA
    Blood Coagul Fibrinolysis; 2004 Apr; 15(3):235-40. PubMed ID: 15060419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.